• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    TriSalus Life Sciences, Inc. - Common Stock (NQ:TLSI)

    6.150 +0.320 (+5.49%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 242,891
    Open 5.800
    Bid (Size) 3.000 (1,000)
    Ask (Size) 6.500 (100)
    Prev. Close 5.830
    Today's Range 5.800 - 6.330
    52wk Range 3.420 - 7.950
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
    From TriSalus Life Sciences
    Via Business Wire

    Performance

    YTD
    +0.8%
    +0.8%
    1 Month
    -17.1%
    -17.1%
    3 Month
    +29.5%
    +29.5%
    6 Month
    +30.3%
    +30.3%
    1 Year
    +28.1%
    +28.1%

    More News

    Read More
    News headline image
    TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    News headline image
    TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q3 2025 Results with Strong Revenue Growth but Significant EPS Miss ↗
    Via Chartmill
    News headline image
    TriSalus (TLSI) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Participate in Upcoming Investor Conferences
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Strong Q2 2025 Revenue Growth and Narrowed Losses ↗
    Via Chartmill
    News headline image
    TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    Earnings Scheduled For August 12, 2025 ↗
    Via Benzinga
    News headline image
    TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    Earnings Scheduled For May 15, 2025 ↗
    Via Benzinga
    News headline image
    TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
    From TriSalus Life Sciences
    Via Business Wire
    News headline image
    TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
    From TriSalus Life Sciences
    Via Business Wire

    Frequently Asked Questions

    Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
    Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
    What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
    TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
    The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
    What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
    The current price of TriSalus Life Sciences, Inc. - Common Stock is 6.150
    When was TriSalus Life Sciences, Inc. - Common Stock last traded?
    The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 01/15/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.